PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1742877
PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1742877
Global Blood Banking Devices Market to Reach US$31.7 Billion by 2030
The global market for Blood Banking Devices estimated at US$22.9 Billion in the year 2024, is expected to reach US$31.7 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Blood Collection Devices, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$8.9 Billion by the end of the analysis period. Growth in the Blood Processing Devices segment is estimated at 4.0% CAGR over the analysis period.
The U.S. Market is Estimated at US$6.3 Billion While China is Forecast to Grow at 9.0% CAGR
The Blood Banking Devices market in the U.S. is estimated at US$6.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.5 Billion by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.
Global Blood Banking Devices Market - Key Trends & Drivers Summarized
Why Are Blood Banking Devices Gaining Strategic Significance in Transfusion Medicine, Public Health Preparedness, and Clinical Supply Chain Optimization?
Blood banking devices are essential for the safe collection, processing, storage, and distribution of blood and its components, forming the operational backbone of transfusion services and emergency medical response systems. As global demand for blood products rises-driven by trauma care, surgical interventions, cancer therapies, and hematological disorders-health systems are increasingly prioritizing automation, standardization, and traceability within blood bank workflows. Devices such as blood collection monitors, centrifuges, leukoreduction filters, component separators, and automated storage systems are critical in maintaining product quality, minimizing wastage, and ensuring donor-to-recipient safety.
The strategic importance of blood banking infrastructure has been reinforced by recent global health emergencies, where rapid mobilization of blood supplies and robust donor management systems have proven essential. Devices that enable faster, sterile, and high-yield processing of blood components support public health resiliency, particularly in low-resource settings or during outbreaks, natural disasters, and mass casualty scenarios. Moreover, the growing emphasis on patient blood management (PBM) is increasing reliance on precise and consistent processing technologies to reduce unnecessary transfusions and improve clinical outcomes.
As healthcare moves toward centralized laboratory services and integrated care models, blood banking devices are becoming part of larger diagnostic and therapeutic ecosystems. Their role extends beyond logistics and storage to include data interoperability, compliance assurance, and quality control-making them integral to value-based care delivery in hospitals, blood centers, and national transfusion networks.
How Are Automation, Cold Chain Innovation, and Digital Integration Enhancing Efficiency and Reliability in Blood Banking?
Automation is reshaping blood bank operations by reducing manual error, increasing throughput, and standardizing process parameters. Automated blood component separators, plasma extractors, and tube sealers are enabling high-volume, high-precision processing of whole blood into red cells, plasma, and platelets. These systems are essential for meeting stringent regulatory standards on sterility, yield, and component separation timelines, particularly in high-demand or multi-shift operational settings.
Advanced refrigeration and cold chain devices-such as temperature-monitored blood bank refrigerators, platelet incubators, and plasma freezers-are ensuring temperature integrity and compliance with AABB, FDA, and WHO guidelines. Real-time temperature logging, deviation alerts, and remote monitoring capabilities reduce product loss and enhance audit readiness. Additionally, solar-powered and battery-backed cold storage systems are extending access to reliable blood product storage in off-grid or mobile environments.
Digital integration is enabling end-to-end visibility across blood banking workflows. Integration with Laboratory Information Systems (LIS), inventory tracking modules, and RFID-enabled labeling systems supports donor traceability, inventory optimization, and transfusion compatibility checks. Cloud-based platforms are allowing centralized oversight of multi-site operations, while AI and predictive analytics are beginning to play a role in forecasting blood demand, optimizing donor outreach, and minimizing shelf-life expiration across regional networks.
Which Healthcare Systems, End-Use Segments, and Regional Markets Are Driving Adoption of Blood Banking Devices?
Hospitals, standalone blood banks, military field units, and national transfusion services are the primary adopters of blood banking devices. Large academic medical centers and trauma facilities require integrated systems for on-demand component preparation and transfusion safety, while mobile collection units and rural health programs prioritize compact, rugged, and automated solutions suitable for decentralized settings. The expansion of public-private blood bank partnerships and voluntary donor programs is further amplifying device demand across both government and NGO-driven networks.
North America and Western Europe dominate the market in terms of technological sophistication, regulatory compliance, and infrastructure density. However, Asia-Pacific and parts of Latin America are experiencing the fastest growth, fueled by rising surgical volumes, maternal and neonatal care demands, and improving health system financing. Countries like India, China, Brazil, and Indonesia are scaling up national blood services through donor education, improved screening, and expanded cold chain logistics, driving significant procurement of advanced blood banking equipment.
Procurement models are increasingly focused on lifecycle value, encompassing equipment performance, service uptime, regulatory documentation, and training support. Turnkey packages including hardware, software, and after-sales service are gaining favor, particularly in multi-site networks and public health systems. As procurement priorities evolve toward total cost of ownership and clinical integration, suppliers offering scalable, digitally enabled, and standards-compliant solutions are gaining competitive traction.
What Are the Factors Driving Growth in the Blood Banking Devices Market?
The blood banking devices market is expanding as healthcare systems prioritize safe, efficient, and traceable transfusion workflows in response to rising procedural volumes, chronic disease burdens, and public health preparedness mandates. These devices are enabling higher product yield, enhanced safety, and streamlined operations across donor-to-recipient pathways.
Key growth drivers include the rise in surgical and trauma-related transfusions, increased automation in blood processing, digital integration of donor and inventory data, and growing investment in transfusion infrastructure across emerging markets. Enhanced compliance requirements and global initiatives in blood safety are further catalyzing technology adoption.
As precision in transfusion medicine becomes inseparable from operational resilience and patient safety, could blood banking devices emerge as critical enablers of a more responsive, digitized, and globally connected blood supply ecosystem?
SCOPE OF STUDY:
The report analyzes the Blood Banking Devices market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Product Type (Blood Collection Devices, Blood Processing Devices, Blood Storage Devices, Blood Transfusion Devices, Blood Grouping / Testing Reagents, Other Product Types); Collection Method (Manual Blood Collection, Automated Blood Collection); End-User (Hospitals, Clinics, Blood Banks, Other End-Users)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 42 Featured) -
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.
We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.
As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.
To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!
APRIL 2025: NEGOTIATION PHASE
Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.
JULY 2025 FINAL TARIFF RESET
Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.
Reciprocal and Bilateral Trade & Tariff Impact Analyses:
USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.
Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.
COMPLIMENTARY PREVIEW
Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.